Barclays’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9M Sell
167,727
-191,194
-53% -$13.9M ﹤0.01% 1353
2026
Q1
$23.4M Buy
358,921
+95,536
+36% +$7.1M 0.01% 1028
2025
Q4
$20.9M Sell
263,385
-76,202
-22% -$5.84M 0.01% 1235
2025
Q3
$24.8M Sell
339,587
-67,814
-17% -$4.97M 0.01% 1103
2025
Q2
$30.9M Buy
407,401
+84,354
+26% +$5.97M 0.01% 909
2025
Q1
$24.6M Buy
323,047
+60,385
+23% +$4.5M 0.01% 930
2024
Q4
$17.4M Sell
262,662
-66,324
-20% -$4.64M ﹤0.01% 1202
2024
Q3
$22.9M Sell
328,986
-369,619
-53% -$22.2M 0.01% 995
2024
Q2
$36.9M Buy
+698,605
New +$42.4M 0.01% 715

Other funds holding SOLV

Barclays's SOLV Position: Q2 2026 in Review

Barclays reduced its Solventum (SOLV) stake by 53% in Q2 2026, selling an estimated $13.9M and leaving 167,727 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1353.

Barclays first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $36.9M in Q2 2024. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Barclays held 167,727 shares of Solventum worth $12.9M as of Q2 2026.
  • Barclays sold 191,194 Solventum shares in Q2 2026, an estimated $13.9M.
  • Solventum made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1353 holding.
  • Barclays first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Barclays's Solventum position peaked at $36.9M in Q2 2024.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.